TK
Alpha Teknova, Inc.
TKNO · NASDAQ
$7.79 +6.13% (+$0.45)
1M +11.29%
Market Cap $399.4M
P/E Ratio -
Div. Yield -
ROE 24.94%
Piotroski F-Score Weak
3/9Valuation
10 /100
Expensive P/S 9.14x
P/B 6.38x
P/E N/A
Growth
12 /100
Declining Rev. growth 0.73%
Book val. growth 11.70%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 33.94%
FCF margin 16.37%
Net margin 38.37%
Quality
6 /100
Poor ROIC 17.48%
Asset turnover 0.46x
ROE 24.94%
Debt
64 /100
Moderate Debt/Equity 0.44x
Int. coverage -18.12x
Current ratio 4.49x
Stability
83 /100
Stable Beta 0.73x
Profitable years 0
Rev. volatility 9.82%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TKNO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Stephen Gunstream
Employees
158
Headquarters
Hollister
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report